SCHEMBL1628854

SCHEMBL1628854

O=C(Nc1ccccc1)c1cc(-c2ccnn2-c2ccccc2Cl)c(O)cc1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 5/20 0.51
TMPRSS4 Q9NRS4 1/20 0.49
NR3C2 P08235 1/20 0.47
HSP90AB1 P08238 1/20 0.45
JAK2 O60674 2/20 0.43
TYK2 P29597 2/20 0.43
JAK1 P23458 1/20 0.43
JAK3 P52333 1/20 0.43
KCNMA1 Q12791 2/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 1/20 0.42
RIPK1 Q13546 1/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
CYP1A2 P05177 2/20 0.41
HTT P42858 2/20 0.41
HPGD P15428 2/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1629002 0.87 HSP90AA1 (0.53) HSP90AA1NR3C2JAK2TYK2JAK1
SCHEMBL1629007 0.84 HSP90AA1 (0.53) HSP90AA1NR3C2HSP90AB1JAK2TYK2
SCHEMBL1628861 0.81 HSP90AA1 (0.55) HSP90AA1NR3C2JAK2TYK2JAK1
SCHEMBL1629132 0.80 HSP90AA1 (0.56) HSP90AA1NR3C2HSP90AB1JAK2TYK2
SCHEMBL1630079 0.78 HSP90AA1 (0.60) HSP90AA1NR3C2HSP90AB1P2RX7LMNA
SCHEMBL1630205 0.77 HSP90AA1 (0.50) HSP90AA1NR3C2HSP90AB1KDM4E
SCHEMBL1630247 0.77 HSP90AA1 (0.56) HSP90AA1NR3C2HSP90AB1CYP2C9
SCHEMBL1630551 0.77 HSP90AA1 (0.62) HSP90AA1NR3C2RAB9AKMT2AHTT
SCHEMBL1219136 0.76 HSP90AA1 (0.61) HSP90AA1HSP90AB1
SCHEMBL1628953 0.75 HSP90AA1 (0.72) HSP90AA1NR3C2JAK2TYK2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP claimed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US claimed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US claimed
CN-101006061-A 1,5-diphenylpyrazoles MERCK PATENT GMBH (DE) 2007-07-25 CN claimed
EP-1776346-A1 1,5-DIPHENYLPYRAZOLES Merck Patent GmbH (DE) 2007-04-25 EP claimed
WO-2006018082-A1 1,5-DIPHENYLPYRAZOLES MERCK PATENT GMBH (DE) 2006-02-23 WO claimed
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed
CN-101006061-A 1,5-diphenylpyrazoles MERCK PATENT GMBH (DE) 2007-07-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885TMPRSS4 3032/4885NR3C2 558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.